Stay updated on ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM
Sign up to get notified when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.

Latest updates to the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page
- ChecktodayChange DetectedA MedlinePlus Genetics resource reference related to multiple myeloma was removed from the page. The clinical trial details remain unchanged.SummaryDifference0.1%

- Check7 days agoChange DetectedThe NIH site-wide announcement about the transition from “Artificial Intelligence” to “Super Intelligence” terminology was removed.SummaryDifference1%

- Check14 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0. The study page still displays a 403 error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide NIH notice appears above the ClinicalTrials.gov page, announcing a terminology change from “Artificial Intelligence” to “Super Intelligence” and linking to transition updates.SummaryDifference1%

- Check28 days agoChange DetectedThe ClinicalTrials.gov page's footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe error page’s footer revision label changes from v3.7.0 to v3.7.1; the study record remains inaccessible.SummaryDifference0.2%

Stay in the know with updates to ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM
Enter your email address, and we'll notify you when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.